--- title: "ABBOTT LABORATORIES LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/85e99361-99fa-5f40-a41b-f6b10073845e json: https://whiteintel.dev/api/public/dossier/85e99361-99fa-5f40-a41b-f6b10073845e identifier: oo:GB-COH-00329102 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # ABBOTT LABORATORIES LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-00329102` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/85e99361-99fa-5f40-a41b-f6b10073845e **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/85e99361-99fa-5f40-a41b-f6b10073845e ## Cross-source identity The same real-world entity, resolved across sources: - **Abbott Laboratories Ltd** — source · `gb-coh:329102` — https://whiteintel.dev/entity/05aea907-db92-4eed-be37-a919a55028ec - **ABBOTT LABORATORIES LIMITED** — GLEIF · `lei:549300SNC3T2M72IGF87` — https://whiteintel.dev/entity/6cb276eb-fb2d-58f0-be62-e4399c65f7c2 ## Ownership & control ### Owners / controllers - **ABBOTT (UK) HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/cb3e3cb5-8877-522d-b6b9-c43d3380a406 - **Abbott Uk Holdings Ltd** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/9d88cbb7-33e0-430c-accc-3c5675f46436 ### Holdings / subsidiaries - **LINGO TECHNOLOGY UK LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/ec861c2c-50a2-577e-9648-f0f6567184d6 - **ABBOTT (UK) FINANCE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/6f0c58ec-01df-539b-9ba0-1fae3bab339e - **MUREX BIOTECH LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/22f715ea-c6e0-5809-8058-1937608d1894 - **ABBOTT LABORATORIES TRUSTEE COMPANY LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/ae67fb77-e950-5edd-9fa3-f804ab94b550 - **ABBOTT DIABETES CARE LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/57f16670-20ca-5f39-be26-fd4110ec07ad - **LINGO TECHNOLOGY UK LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/ec861c2c-50a2-577e-9648-f0f6567184d6 - **ABBOTT (UK) FINANCE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/6f0c58ec-01df-539b-9ba0-1fae3bab339e - **ABBOTT DIABETES CARE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/57f16670-20ca-5f39-be26-fd4110ec07ad ### UBO chain (walk to the ultimate owner) A **8-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `00329102` - **Status:** active - **Type:** ltd - **Incorporated:** 1937-06-23 - **Registered office:** Abbott House Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE - **SIC:** 46460 ### Officers - GOGAY, Kevan — secretary · appointed 2013-01-01 - CAMPBELL, Ross Iain — director · British · appointed 2025-04-25 - CLAYTON, Michael Robert Kendall — director · British · appointed 2020-03-23 - WENNER, James Russell — director · American · appointed 2025-12-17 - BEATTIE, Philip — secretary · British · appointed 1993-02-17 · resigned 2003-04-01 - BROWN, Stephen — secretary · British · appointed 2005-10-01 · resigned 2011-06-07 - COLLINS, Michael Cyril — secretary · British · resigned 1993-02-17 - MARK, David — secretary · American · appointed 2003-04-01 · resigned 2005-10-01 - POOTS, Kyle — secretary · appointed 2011-06-06 · resigned 2013-01-01 - BEATTIE, Philip — director · British · resigned 1993-02-17 - BRANIGHAN, Kenneth Robert — director · Australian · appointed 2001-01-16 · resigned 2002-05-31 - BROWN, Stephen — director · British · appointed 2005-11-30 · resigned 2006-02-02 - BRYANT, Douglas — director · British · appointed 1995-05-22 · resigned 1997-09-12 - COUGHLAN, Gary Patrick — director · American · appointed 1993-02-17 · resigned 2001-03-31 - COULTER, John — director · Canadian · appointed 2006-03-02 · resigned 2007-03-30 - DAVIES, Alison Elizabeth — director · British · appointed 2023-09-18 · resigned 2025-12-17 - DAVIS, Kirk — director · Usa · appointed 1996-01-15 · resigned 1998-02-16 - FORREST, Andrew David Hall — director · British · appointed 2004-12-13 · resigned 2007-10-25 - FREYMAN, Thomas Craig — director · American · appointed 2001-04-02 · resigned 2015-12-15 - FUNCK, Robert Emmett — director · American · appointed 2007-03-30 · resigned 2007-12-03 ### Beneficial owners (Persons with Significant Control) - [Abbott Uk Holdings Limited](https://whiteintel.dev/entity/9d88cbb7-33e0-430c-accc-3c5675f46436) — 75–100% shares · corporate PSC · England — since 2016-04-06 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/00329102 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/00329102 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **ABBOTT LABORATORIES LIMITED** — https://whiteintel.dev/entity/85e99361-99fa-5f40-a41b-f6b10073845e · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **ABBOTT LABORATORIES LIMITED**. Human view: https://whiteintel.dev/entity/85e99361-99fa-5f40-a41b-f6b10073845e · Structured JSON: https://whiteintel.dev/api/public/dossier/85e99361-99fa-5f40-a41b-f6b10073845e._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._